Medical - Diagnostics & Research
50 companies in this industry
Insider Buys (30d)
2
$9.7K
Insider Sells (30d)
72
$476.62M
Top Companies by Market Cap
TMOThermo Fisher Scientific Inc.
$225.09BDHRDanaher Corporation
$144.11BNTRANatera, Inc.
$47.31BIQVIQVIA Holdings Inc.
$42.30BAAgilent Technologies, Inc.
$40.89BIDXXIDEXX Laboratories, Inc.
$40.64BILMNIllumina, Inc.
$31.24BWATWaters Corporation
$30.54BMTDMettler-Toledo International Inc.
$26.14BDGXQuest Diagnostics Incorporated
$25.94BRecent Insider Trades
| Date | Ticker | Company | Insider | Role | Type | Shares | Avg Price | Value |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | CSTL | Castle Biosciences, Inc. | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | Sell | 14,518 | $32.02 | $464.9K |
| Sep 14, 2026 | GH | Guardant Health, Inc. | Kalia Kumud | officer: Chief Information Officer | Sell | 4,000 | $158.05 | $632.2K |
| Sep 11, 2026 | WGS | GeneDx Holdings Corp. | Feeley Kevin | officer: CHIEF FINANCIAL OFFICER | Sell | 1,285 | $84.22 | $108.2K |
| Sep 11, 2026 | SERA | Sera Prognostics, Inc. | Inglis Tiffany Eul Davis | officer: Chief Medical Officer | Sell | 486 | $2.00 | $972.00 |
| Sep 11, 2026 | SERA | Sera Prognostics, Inc. | Anderson Dyaarl Lee Jr. | officer: Chief Commercial Officer | Sell | 1,800 | $2.00 | $3.6K |
| Sep 11, 2026 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | director, officer: Chief Executive Officer | Sell | 7,022 | $2.00 | $14.0K |
| Sep 11, 2026 | WGS | GeneDx Holdings Corp. | Stueland Katherine | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 3,692 | $84.22 | $310.9K |
| Sep 11, 2026 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | officer: General Counsel | Sell | 2,190 | $2.00 | $4.4K |
| Sep 11, 2026 | NTRA | Natera, Inc. | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 50,000 | $327.97 | $16.40M |
| Sep 9, 2026 | BNGO | Bionano Genomics, Inc. | Luderer Albert | director, officer: Interim Chief Executive | Buy | 4,000 | $1.21 | $4.8K |
| Sep 9, 2026 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | director, officer: Chief Executive Officer | Sell | 20,139 | $2.00 | $40.3K |
| Sep 9, 2026 | IDXX | IDEXX Laboratories, Inc. | Kingsley Lawrence D | director | Sell | 2,203 | $532.08 | $1.17M |
| Sep 9, 2026 | A | Agilent Technologies, Inc. | Dolsten Mikael | director | Sell | 634 | $151.38 | $96.0K |
| Sep 4, 2026 | ILMN | Illumina, Inc. | Meister Keith A. | director | Sell | 263,560 | $217.03 | $57.20M |
| Sep 4, 2026 | VCYT | Veracyte, Inc. | McGuire Annie | officer: EVP, General Counsel | Sell | 3,254 | $43.09 | $140.2K |
| Sep 4, 2026 | IQV | IQVIA Holdings Inc. | Berkshire James G. | officer: See Remarks | Sell | 2,668 | $261.33 | $697.2K |
| Sep 4, 2026 | VCYT | Veracyte, Inc. | Febbo Phillip G. | officer: Chief Scientific & Med Officer | Sell | 13,110 | $43.05 | $564.4K |
| Sep 4, 2026 | VCYT | Veracyte, Inc. | Chambers Rebecca | officer: Chief Financial Officer | Sell | 3,652 | $43.10 | $157.4K |
| Sep 3, 2026 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | officer: Chief Scientific Officer | Sell | 1,673 | $19.66 | $32.9K |
| Sep 3, 2026 | NTRA | Natera, Inc. | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 1,698 | $320.99 | $545.0K |
| Sep 3, 2026 | NTRA | Natera, Inc. | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 18,160 | $325.88 | $5.92M |
| Sep 3, 2026 | CSTL | Castle Biosciences, Inc. | Oelschlager Kristen M | officer: Chief Operating Officer | Sell | 4,152 | $33.39 | $138.6K |
| Sep 3, 2026 | FLGT | Fulgent Genetics, Inc. | Xie Jian | officer: President and COO | Sell | 2,127 | $19.66 | $41.8K |
| Sep 3, 2026 | WGS | GeneDx Holdings Corp. | Feeley Kevin | officer: CHIEF FINANCIAL OFFICER | Sell | 372 | $83.84 | $31.2K |
| Sep 3, 2026 | DGX | Quest Diagnostics Incorporated | Davis J. E. | director, officer: CEO and President | Sell | 10,000 | $242.72 | $2.43M |
| Sep 3, 2026 | VCYT | Veracyte, Inc. | Bhanji Muna | director | Sell | 1,864 | $42.97 | $80.1K |
| Sep 2, 2026 | CSTL | Castle Biosciences, Inc. | Juvenal Tobin W | officer: Chief Commercial Officer | Sell | 1,730 | $32.81 | $56.8K |
| Sep 2, 2026 | XGN | Exagen Inc. | Black Jeffrey G. | officer: Chief Financial Officer | Sell | 20,614 | $7.22 | $148.8K |
| Sep 1, 2026 | CSTL | Castle Biosciences, Inc. | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | Sell | 17,726 | $33.20 | $588.4K |
| Sep 1, 2026 | TMO | Thermo Fisher Scientific Inc. | Pettiti Gianluca | officer: President & COO | Sell | 3,733 | $614.38 | $2.29M |
| Aug 31, 2026 | DGX | Quest Diagnostics Incorporated | PREVOZNIK MICHAEL E | officer: SVP & General Counsel | Sell | 22,677 | $243.11 | $5.51M |
| Aug 31, 2026 | MEDP | Medpace Holdings, Inc. | Troendle August J. | director, 10 percent owner, officer: President & CEO | Sell | 650 | $620.27 | $403.2K |
| Aug 31, 2026 | GRAL | GRAIL Inc. | Freidin Aaron | officer: Chief Financial Officer | Sell | 7,900 | $85.01 | $671.6K |
| Aug 31, 2026 | MTD | Mettler-Toledo International Inc. | Kaltenbach Patrick | officer: President and CEO | Sell | 942 | $1425.00 | $1.34M |
| Aug 31, 2026 | GRAL | GRAIL Inc. | Ofman Joshua J. | director, officer: Chief Executive Officer | Sell | 5,000 | $85.02 | $425.1K |
| Aug 28, 2026 | FLGT | Fulgent Genetics, Inc. | Xie Jian | officer: President and COO | Sell | 1,193 | $19.91 | $23.7K |
| Aug 28, 2026 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | officer: Chief Scientific Officer | Sell | 939 | $19.91 | $18.7K |
| Aug 28, 2026 | NTRA | Natera, Inc. | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 6,517 | $321.53 | $2.10M |
| Aug 28, 2026 | MEDP | Medpace Holdings, Inc. | Kraft Robert O. | director | Sell | 3,858 | $617.81 | $2.38M |
| Aug 27, 2026 | ILMN | Illumina, Inc. | Meister Keith A. | director | Sell | 375,941 | $226.74 | $85.24M |
| Aug 27, 2026 | CSTL | Castle Biosciences, Inc. | Juvenal Tobin W | officer: Chief Commercial Officer | Sell | 9,050 | $35.04 | $317.1K |
| Aug 27, 2026 | TWST | Twist Bioscience Corporation | Leproust Emily M. | director, officer: Chief Executive Officer | Sell | 41,570 | $151.98 | $6.32M |
| Aug 27, 2026 | MEDP | Medpace Holdings, Inc. | Troendle August J. | director, 10 percent owner, officer: President & CEO | Sell | 4,673 | $620.08 | $2.90M |
| Aug 27, 2026 | CRL | Charles River Laboratories International, Inc. | FOSTER JAMES C | director | Sell | 33,561 | $300.00 | $10.07M |
| Aug 26, 2026 | TMO | Thermo Fisher Scientific Inc. | CASPER MARC N | director, officer: Chairman & CEO | Sell | 275 | $627.05 | $172.4K |
| Aug 26, 2026 | CSTL | Castle Biosciences, Inc. | Oelschlager Kristen M | officer: Chief Operating Officer | Sell | 24,602 | $34.06 | $837.9K |
| Aug 25, 2026 | TWST | Twist Bioscience Corporation | Green Paula | officer: SVP of Human Resources | Sell | 1,360 | $139.07 | $189.1K |
| Aug 25, 2026 | MEDP | Medpace Holdings, Inc. | Troendle August J. | director, 10 percent owner, officer: President & CEO | Sell | 15,978 | $623.93 | $9.97M |
| Aug 25, 2026 | TWST | Twist Bioscience Corporation | WERNER ROBERT F. | officer: Chief Accounting Officer | Sell | 1,523 | $140.02 | $213.3K |
| Aug 25, 2026 | TWST | Twist Bioscience Corporation | Finn Patrick John | officer: President and COO | Sell | 4,046 | $139.07 | $562.7K |
Showing 1–50 of 74
1 / 2